These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 36739636)
1. Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy. Han N; Yang ZY; Xie ZX; Xu HZ; Yu TT; Li QR; Li LG; Peng XC; Yang XX; Hu J; Xu X; Chen X; Wang MF; Li TF Phytomedicine; 2023 Apr; 112():154682. PubMed ID: 36739636 [TBL] [Abstract][Full Text] [Related]
2. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage. Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440 [TBL] [Abstract][Full Text] [Related]
3. Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer. Bai XF; Hu J; Wang MF; Li LG; Han N; Wang H; Chen NN; Gao YJ; You H; Wang X; Xu X; Yu TT; Li TF; Ren T Eur J Pharmacol; 2024 Sep; 979():176839. PubMed ID: 39033838 [TBL] [Abstract][Full Text] [Related]
4. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS. Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867 [TBL] [Abstract][Full Text] [Related]
5. Inhalable Biomineralized Liposomes for Cyclic Ca Fu F; Wang W; Wu L; Wang W; Huang Z; Huang Y; Wu C; Pan X ACS Nano; 2023 Mar; 17(6):5486-5502. PubMed ID: 36883602 [TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin remodels macrophage into an M1 phenotype Li LG; Peng XC; Yu TT; Xu HZ; Han N; Yang XX; Li QR; Hu J; Liu B; Yang ZY; Xu X; Chen X; Wang MF; Li TF Front Pharmacol; 2022; 13():949835. PubMed ID: 36034842 [TBL] [Abstract][Full Text] [Related]
7. Fe-MnO Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713 [TBL] [Abstract][Full Text] [Related]
8. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage. Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571 [TBL] [Abstract][Full Text] [Related]
9. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy. Han W; Duan X; Ni K; Li Y; Chan C; Lin W Biomaterials; 2022 Jan; 280():121315. PubMed ID: 34920370 [TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage. Li LG; Peng XC; Yang ZY; Han N; Gou CL; Shi J; Yu LL; Chen NN; Yu TT; Li TF; Li XY; Hu J Sci Rep; 2024 May; 14(1):11704. PubMed ID: 38778121 [TBL] [Abstract][Full Text] [Related]
12. Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells. Li X; Zhu S; Li Z; Meng YQ; Huang SJ; Yu QY; Li B Free Radic Res; 2022; 56(5-6):398-410. PubMed ID: 36194238 [TBL] [Abstract][Full Text] [Related]
13. S. glabra exerts anti-lung cancer effects by inducing ferroptosis and anticancer immunity. Liu S; Zhang L; Ding K; Zeng B; Li B; Zhou J; Li J; Wang J; Zhang H; Sun R; Su X Phytomedicine; 2024 Nov; 134():155981. PubMed ID: 39260134 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide water-driven immunogenic cell death: Unfolding mitochondrial dysfunction's role in sensitizing lung adenocarcinoma to ferroptosis and autophagic cell death. Negi M; Kaushik N; Lamichhane P; Patel P; Jaiswal A; Choi EH; Kaushik NK Free Radic Biol Med; 2024 Sep; 222():1-15. PubMed ID: 38763209 [TBL] [Abstract][Full Text] [Related]
16. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872 [TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro. Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601 [TBL] [Abstract][Full Text] [Related]
18. Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death. Hu Q; Wang S; Cheng R; Liu Y; Chang Z; Huang Y; Chen Y; Luo X; Zhou L; Wang B; Gao Y; Chen H; Liu R; Zhang L Phytomedicine; 2024 Jan; 123():155219. PubMed ID: 38056150 [TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193 [TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4‑CHOP signaling pathway. Tang N; Liu X; Liu Y; Wang H; Zhao Y; Wang H; Hu Z Oncol Lett; 2024 Jul; 28(1):337. PubMed ID: 38846431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]